WallStreetZenWallStreetZen

NASDAQ: HCSG
Healthcare Services Group Inc Stock Forecast, Predictions & Price Target

Analyst price target for HCSG

Based on 4 analysts offering 12 month price targets for Healthcare Services Group Inc.
Min Forecast
$13.00+8.88%
Avg Forecast
$14.50+21.44%
Max Forecast
$17.00+42.38%

Should I buy or sell HCSG stock?

Based on 4 analysts offering ratings for Healthcare Services Group Inc.
Buy
Strong Buy
1 analysts 25%
Buy
1 analysts 25%
Hold
2 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HCSG stock forecasts and price targets.

HCSG stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-15
lockedlocked$00.00+00.00%2024-02-15
lockedlocked$00.00+00.00%2024-02-15
lockedlocked$00.00+00.00%2024-02-15

1 of 1

Forecast return on equity

Is HCSG forecast to generate an efficient return?

Forecast return on assets

Is HCSG forecast to generate an efficient return on assets?

HCSG revenue forecast

What is HCSG's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.7B+3.41%
Avg 2 year Forecast
$1.8B+7.11%
HCSG's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HCSG revenue growth forecast

How is HCSG forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
3.41%
Industry
6.61%
Market
13.2%
HCSG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HCSG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HCSG vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
HCSG$11.94$14.50+21.44%Buy
MD$9.03$9.38+3.82%Hold
PNTG$20.30$20.33+0.16%Buy
CCRN$17.50$20.80+18.86%Buy
CMPS$8.38$55.33+560.30%Strong Buy

Healthcare Services Group Stock Forecast FAQ

Is Healthcare Services Group Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: HCSG) stock is to Buy HCSG stock.

Out of 4 analysts, 1 (25%) are recommending HCSG as a Strong Buy, 1 (25%) are recommending HCSG as a Buy, 2 (50%) are recommending HCSG as a Hold, 0 (0%) are recommending HCSG as a Sell, and 0 (0%) are recommending HCSG as a Strong Sell.

If you're new to stock investing, here's how to buy Healthcare Services Group stock.

What is HCSG's revenue growth forecast for 2024-2025?

(NASDAQ: HCSG) Healthcare Services Group's forecast annual revenue growth rate of 3.41% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.2%.

Healthcare Services Group's revenue in 2024 is $1,671,389,000.On average, 1 Wall Street analysts forecast HCSG's revenue for 2024 to be $127,180,952,262, with the lowest HCSG revenue forecast at $127,180,952,262, and the highest HCSG revenue forecast at $127,180,952,262.

In 2025, HCSG is forecast to generate $131,735,743,367 in revenue, with the lowest revenue forecast at $131,735,743,367 and the highest revenue forecast at $131,735,743,367.

What is HCSG's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: HCSG) forecast ROA is N/A, which is lower than the forecast US Medical Care Facilities industry average of 6.14%.

What is HCSG's Price Target?

According to 4 Wall Street analysts that have issued a 1 year HCSG price target, the average HCSG price target is $14.50, with the highest HCSG stock price forecast at $17.00 and the lowest HCSG stock price forecast at $13.00.

On average, Wall Street analysts predict that Healthcare Services Group's share price could reach $14.50 by Feb 15, 2025. The average Healthcare Services Group stock price prediction forecasts a potential upside of 21.44% from the current HCSG share price of $11.94.

What is HCSG's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: HCSG) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.